3,633 Shares in Agilent Technologies, Inc. $A Bought by Vise Technologies Inc.

Vise Technologies Inc. acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,633 shares of the medical research company’s stock, valued at approximately $429,000.

A number of other large investors have also added to or reduced their stakes in A. Stone House Investment Management LLC bought a new position in Agilent Technologies during the first quarter worth about $30,000. Ransom Advisory Ltd bought a new position in shares of Agilent Technologies in the first quarter worth about $32,000. Central Pacific Bank Trust Division acquired a new stake in Agilent Technologies in the second quarter valued at approximately $33,000. Zions Bancorporation National Association UT acquired a new position in Agilent Technologies in the 1st quarter worth about $38,000. Finally, Costello Asset Management INC bought a new position in Agilent Technologies in the 1st quarter valued at approximately $47,000. Institutional investors own 87.41% of the company’s stock.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 12,490 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the sale, the chief executive officer owned 33,448 shares in the company, valued at approximately $5,017,200. This represents a 27.19% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.26% of the company’s stock.

Agilent Technologies Stock Up 0.0%

A stock opened at $146.90 on Friday. The firm has a 50 day moving average of $137.63 and a 200 day moving average of $123.89. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The stock has a market capitalization of $41.65 billion, a PE ratio of 34.48, a price-to-earnings-growth ratio of 4.67 and a beta of 1.29. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting the consensus estimate of $1.37. The company had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. Agilent Technologies’s quarterly revenue was up 10.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th were issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio (DPR) is 23.24%.

Analyst Upgrades and Downgrades

A has been the topic of a number of recent analyst reports. Rothschild Redb raised Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th. Rothschild & Co Redburn began coverage on shares of Agilent Technologies in a research report on Wednesday, October 8th. They set a “buy” rating and a $165.00 price objective on the stock. TD Cowen boosted their target price on Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research report on Tuesday, October 14th. JPMorgan Chase & Co. upped their target price on Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Agilent Technologies in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $149.62.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.